Diamyd Medical AB (publ) DMN.F Stock
Diamyd Medical AB (publ) Price Chart
Diamyd Medical AB (publ) DMN.F Financial and Trading Overview
| Diamyd Medical AB (publ) stock price | 1.21 EUR |
| Previous Close | 0.69 EUR |
| Open | 0.7 EUR |
| Bid | 0.7 EUR x 0 |
| Ask | 0.77 EUR x 0 |
| Day's Range | 0.7 - 0.7 EUR |
| 52 Week Range | 0.65 - 1.78 EUR |
| Volume | 40 EUR |
| Avg. Volume | 107 EUR |
| Market Cap | 56.14M EUR |
| Beta (5Y Monthly) | 2.075862 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DMN.F Valuation Measures
| Enterprise Value | 54.08M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.104651 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Diamyd Medical AB (publ) Stock Price History
| Beta (5Y Monthly) | 2.075862 |
| 52-Week Change | -49.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.78 EUR |
| 52 Week Low | 0.65 EUR |
| 50-Day Moving Average | 1.28 EUR |
| 200-Day Moving Average | 1.27 EUR |
DMN.F Share Statistics
| Avg. Volume (3 month) | 107 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 74.37M |
| Float | 60.87M |
| Short Ratio | N/A |
| % Held by Insiders | 35.22% |
| % Held by Institutions | 0.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.53% |
| Return on Equity (ttm) | -52.091% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -51.10% |
| Gross Profit (ttm) | -3950000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.995 |
| Book Value Per Share (mrq) | 0.086 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Diamyd Medical AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Kungsgatan 29 |
| ZIP | 111 56 |
| Phone | 46 86 61 00 26 |
| Website | https://www.diamyd.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in Type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.
Q&A For Diamyd Medical AB (publ) Stock
What is a current DMN.F stock price?
Diamyd Medical AB (publ) DMN.F stock price today per share is 1.21 EUR.
How to purchase Diamyd Medical AB (publ) stock?
You can buy DMN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diamyd Medical AB (publ)?
The stock symbol or ticker of Diamyd Medical AB (publ) is DMN.F.
Which industry does the Diamyd Medical AB (publ) company belong to?
The Diamyd Medical AB (publ) industry is Biotechnology.
How many shares does Diamyd Medical AB (publ) have in circulation?
The max supply of Diamyd Medical AB (publ) shares is 98.59M.
What is Diamyd Medical AB (publ) Price to Earnings Ratio (PE Ratio)?
Diamyd Medical AB (publ) PE Ratio is now.
What was Diamyd Medical AB (publ) earnings per share over the trailing 12 months (TTM)?
Diamyd Medical AB (publ) EPS is -0.12 EUR over the trailing 12 months.
Which sector does the Diamyd Medical AB (publ) company belong to?
The Diamyd Medical AB (publ) sector is Healthcare.